TradingKey - Hims & Hers Health (HIMS) is due to release its Q1 2026 results after the closing bell today. Below, we outline what investors should watch for in today's report.

TradingKey15 hours ago

Blue Cross Blue Shield Pays $2.67 Billion Settlement, Why ELV Stock Price Wasn’t Dragged Down?

TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a

TradingKeyThu, May 7

UnitedHealth Beats Q1 2026 and Raises Guidance - Is UNH Stock a Buy After Jumping 8%?

UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?

TradingKeyWed, Apr 22

Today’s Market Recap: US-Iran Negotiations Rejected Again, US Stocks Turn From Gains to Losses, Trump Announces Ceasefire Extension

TradingKey - The three major US stock indices closed lower for a second consecutive session as market concerns intensified over the potential breakdown of US-Iran negotiations and the heightened risk of renewed conflict. Following Donald Trump's threat to bomb Iran, the three indices reversed intrad

TradingKeyWed, Apr 22

STAA Surges More Than 20%, Is It Still a Good Buy Now?

TradingKey - After the market close on April 8, 2026, STAAR Surgical (STAA) released preliminary results that surprised the market: net sales for the first quarter of 2026 are expected to exceed $90 million, more than doubling the $42.6 million reported in the same period of 2025. This guidance sign

TradingKeyFri, Apr 10

US-Iran Ceasefire Hits Oil Prices Over 10% as US Stock Futures Surge Pre-Market

Easing tensions in the Middle East triggered a plunge of over 10% in crude oil prices, while the three major U.S. stock index futures and star tech stocks rallied broadly.

TradingKeyWed, Apr 8

KeyAI

